Korro Bio Stock (NASDAQ: KRRO) stock price, news, charts, stock research, profile.
Open | $51.170 |
Close | $54.660 |
Volume / Avg. | 60.791K / 36.851K |
Day Range | 50.980 - 54.965 |
52 Wk Range | 14.000 - 97.910 |
Market Cap | $506.845M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 1.77% |
Days to Cover | 3.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Korro Bio (NASDAQ: KRRO) through any online brokerage.
Other companies in Korro Bio’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Replimune Group (NASDAQ:REPL).
The latest price target for Korro Bio (NASDAQ: KRRO) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 100.00 expecting KRRO to rise to within 12 months (a possible 82.95% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Korro Bio (NASDAQ: KRRO) is $54.66 last updated May 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Korro Bio.
Korro Bio’s Q4 earnings are confirmed for Friday, May 31, 2024.
There is no upcoming split for Korro Bio.
Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.